NDC Compounded Drug 71266-2003-1 Neostigmine Methylsulfate
Injection Intravenous
Compounded Drug Product Information
NDC Crossover Products Matching Neostigmine Methylsulfate
NDC crossover of Neostigmine Methylsulfate with NDC 71266-2003 a human compounded drug with other similar products matching the same substance name (Neostigmine Methylsulfate) and the same administration route (intravenous) or dosage form (injection).
NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
---|---|---|---|---|---|---|
60652-0329-1 | Neostigmine Methylsulfate | Neostigmine Methylsulfate | 5 mL in 1 SYRINGE, PLASTIC | Injection | Intravenous | Ssm Hlth St Clare Hosp-fnton |
65302-501-03 | Neostigmine Methylsulfate | Neostigmine Methylsulfate | 3 mL in 1 SYRINGE | Injection | Intravenous | The Ritedose Corporation |
65302-501-05 | Neostigmine Methylsulfate | Neostigmine Methylsulfate | 5 mL in 1 SYRINGE | Injection | Intravenous | The Ritedose Corporation |
71266-2003-2 | Neostigmine Methylsulfate | Neostigmine Methylsulfate | 5 mL in 1 SYRINGE | Injection | Intravenous | Fagron Compounding Services Llc Dba Fagron Sterile Services Llc Dba Jcb Laboratories |
73702-113-15 | Neostigmine Methylsulfate | Neostigmine Methylsulfate | 5 mL in 1 SYRINGE | Injection | Intravenous | Wells Pharma Of Houston |
73702-113-53 | Neostigmine Methylsulfate | Neostigmine Methylsulfate | 3 mL in 1 SYRINGE | Injection | Intravenous | Wells Pharma Of Houston |
Frequently Asked Questions
What is the NDC number assigned to Neostigmine Methylsulfate?
Neostigmine Methylsulfate was assigned by its manufacturer with NDC product code 71266-2003. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Neostigmine Methylsulfate?
The NDC package code 71266-2003-1 was assigned to a 3 mL in 1 SYRINGE of neostigmine methylsulfate administered intravenous via injection.
Who manufactures this product?
Neostigmine Methylsulfate is manufactured by an outsourced facility and labeled by Fagron Compounding Services Llc Dba Fagron Sterile Services Llc Dba Jcb Laboratories. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 6 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Ssm Hlth St Clare Hosp-Fnton, The Ritedose Corporation, Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories and Wells Pharma of Houston with NDC product codes 60652-0329-1, 65302-501-03, 65302-501-05, 71266-2003-2, 73702-113-15 and 73702-113-53.